Vir Biotechnology, Inc.: pre-tax income or loss from continuing operations

What this measure means

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Exact concept: us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2017-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Vir Biotechnology, Inc.: total assets
• Vir Biotechnology, Inc.: total liabilities
• Vir Biotechnology, Inc.: stockholders equity
• Vir Biotechnology, Inc.: cash and cash equivalents
• Vir Biotechnology, Inc.: net income or loss
• Vir Biotechnology, Inc.: operating cash flow
• Vir Biotechnology, Inc.: capital expenditure payments
• Vir Biotechnology, Inc.: revenue
• Vir Biotechnology, Inc.: contract revenue excluding tax
• Vir Biotechnology, Inc.: financing cash flow
• Vir Biotechnology, Inc.: investing cash flow
• Vir Biotechnology, Inc.: retained earnings or deficit
• Vir Biotechnology, Inc.: basic weighted-average shares
• Vir Biotechnology, Inc.: diluted weighted-average shares
• Vir Biotechnology, Inc.: basic earnings per share
• Vir Biotechnology, Inc.: diluted earnings per share
• Vir Biotechnology, Inc.: income tax expense or benefit
• Vir Biotechnology, Inc.: net property, plant and equipment
• Vir Biotechnology, Inc.: share-based compensation expense
• Vir Biotechnology, Inc.: operating income or loss
• Vir Biotechnology, Inc.: current assets
• Vir Biotechnology, Inc.: current liabilities
• Vir Biotechnology, Inc.: current accounts payable
• Vir Biotechnology, Inc.: net finite-lived intangible assets
• Vir Biotechnology, Inc.: net current accounts receivable
• Vir Biotechnology, Inc.: operating expenses
• Vir Biotechnology, Inc.: cost of revenue
• Vir Biotechnology, Inc.: selling, general and administrative expense
• Vir Biotechnology, Inc.: research and development expense
• Vir Biotechnology, Inc.: common shares outstanding
• Vir Biotechnology, Inc.: cash including restricted cash
• Vir Biotechnology, Inc.: additional paid-in capital
• Vir Biotechnology, Inc.: accumulated other comprehensive income or loss
• Vir Biotechnology, Inc.: total equity including noncontrolling interests
• Vir Biotechnology, Inc.: operating lease right-of-use asset
• Vir Biotechnology, Inc.: operating lease liability
• Vir Biotechnology, Inc.: gross property, plant and equipment
• Vir Biotechnology, Inc.: accumulated depreciation on property, plant and equipment
• Vir Biotechnology, Inc.: net intangible assets excluding goodwill
• Vir Biotechnology, Inc.: other noncurrent liabilities
• Vir Biotechnology, Inc.: prepaid expenses and other current assets
• Vir Biotechnology, Inc.: net deferred tax assets
• Vir Biotechnology, Inc.: net deferred tax liabilities
• Vir Biotechnology, Inc.: profit or loss including noncontrolling interests
• Vir Biotechnology, Inc.: comprehensive income or loss
• Vir Biotechnology, Inc.: net income available to common stockholders
• Vir Biotechnology, Inc.: general and administrative expense
• Vir Biotechnology, Inc.: depreciation expense
• Vir Biotechnology, Inc.: depreciation, depletion and amortization
• Vir Biotechnology, Inc.: amortization of intangible assets
• Vir Biotechnology, Inc.: other nonoperating income or expense
• Vir Biotechnology, Inc.: nonoperating income or expense
• Vir Biotechnology, Inc.: current income tax expense or benefit
• Vir Biotechnology, Inc.: deferred income tax expense or benefit
• Vir Biotechnology, Inc.: income taxes paid, net
• Vir Biotechnology, Inc.: proceeds from issuing common stock
• Vir Biotechnology, Inc.: operating lease payments
• Vir Biotechnology, Inc.: change in accounts receivable
• Vir Biotechnology, Inc.: change in accounts payable

Inspect the source

Entity

Vir Biotechnology, Inc. / CIK 0001706431

Captured

2026-09-21T17:26:14.950Z

SEC response SHA-256

193c306076963bcf8644e9b0874496f847206ef65b610957874753098340c4c0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001706431.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))